The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Could Controlled Imaging Rein in Suboptimal Use of MRI, CT and Ultrasound Exams?
April 24th 2023Lamenting a lack of control over imaging requests from referring clinicians, this author suggests that a more collaborative approach between referrers and radiologists may facilitate more efficient use of imaging.
Spine Radiology Insights on Venous Fistula Localization and Finding Cerebrospinal Fluid Leaks
April 19th 2023In a recent lecture at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting, Andrew Callen, M.D., discussed a variety of imaging features associated with cerebrospinal fluid (CSF) leaks, the diagnostic utility of the Bern score as well as the merits of 3D T2FS MRI and dynamic computed tomography myelography.
Breast Reconstruction: Current Principles and Emerging Concepts in Imaging
April 17th 2023Given the increasing prevalence of breast reconstruction, researchers discussed key signs of common complications on magnetic resonance imaging (MRI), ultrasound and other imaging during a recent presentation at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
Award-Winning Study Shows Benefits of 3D MRI for Assessing the Fetal Optic Pathway
April 16th 2023Three-dimensional (3D) slice-to-volume (SVR) fetal magnetic resonance imaging (MRI) has over six times the fetal optic pathway visualization rate of standard two-dimensional MRI, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
New Medtronic App Streamlines MRI Screening for Patients with Cardiac Devices
April 5th 2023Offering built-in safety features and independent verification of magnetic resonance imaging (MRI) compatibility with cardiac devices such as pacemakers or implantable cardioverter defibrillator systems, the MRI Care Pathway app may enhance the efficiency of radiology workflows for MRI scans in patients with these devices.
Seven Takeaways from New Consensus Recommendations for Cardiac MRI Assessment of COVID-19
March 31st 2023Consensus recommendations from the Society for Cardiovascular Magnetic Resonance provide pertinent insights on the unique abilities of cardiac magnetic resonance imaging (MRI) to provide optimal characterization of myocardial tissue and diagnosis of COVID-19-related myocardial injuries.
What a Breast MRI Study Reveals About Axillary Lymph Nodes and COVID-19 Booster Vaccination
March 21st 2023In a study of 128 patients who had breast magnetic resonance imaging (MRI) exams after COVID-19 booster vaccination, researchers noted that nearly 19 percent of the cohort had equal to or greater than 0.2 cm of increased lymph node cortical thickness.
Could Cardiac MRI Improve Risk Stratification in Patients with Dilated Cardiomyopathy?
March 20th 2023Emerging research suggests that cardiac MRI findings of late gadolinium enhancement, native T1 values and extracellular volume fraction may predict sudden cardiac death-related events in patients with nonischemic dilated cardiomyopathy.
Seven Key Considerations with Rectal Cancer MRI
March 3rd 2023In a cum laude awarded presentation at the European Congress of Radiology (ECR), researchers discussed misconceptions and pertinent principles for magnetic resonance imaging (MRI) of patients with rectal cancer, ranging from the diagnosis of mucinous tumors to the impact of mesorectal fascia status for rectal cancer recurrence.
Cancer Screenings and COVID-19: What a New Study Shows
February 27th 2023New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.
Current Perspectives on the BCLC Staging System for Hepatocellular Carcinoma
February 24th 2023Reviewing recent changes to the Barcelona Clinic Liver Cancer (BCLC) staging system for hepatocellular carcinoma and the potential impact for interventional radiologists, these authors discuss key updates including the subdivision of patients with intermediate stage disease and emerging literature on systemic agents for advanced disease.
Can Pre-Op Ultrafast MRI Predict Upgrade of DCIS Lesions to Invasive Breast Cancer?
February 9th 2023In a new study that may have implications for breast cancer surgery, researchers found that shorter time to enhancement (TTE) on preoperative ultrafast magnetic resonance imaging (MRI) was significantly associated with escalation of ductal carcinoma in situ (DCIS) to invasive breast cancer.
Interval Breast Cancer: What a New Mammography Study Reveals
February 6th 2023In a new study of 1,232 women diagnosed with breast cancer within a year of a screening mammography exam, researchers found that interval breast cancer was 17 percent more likely in women with dense or extremely dense breasts, and over three times more likely to involve stage 2 or higher primary tumors in comparison to screening-detected breast cancer.